GO ID |
Ontology |
GO Term |
Term Definition |
Proteins |
GO:0032600
|
BP
|
chemokine receptor transport out of membrane raft
|
The directed movement of a chemokine receptor out of a membrane raft.
|
CD24
|
GO:0032602
|
BP
|
chemokine production
|
The appearance of a chemokine due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
S100A8,
S100A9
|
GO:0032606
|
BP
|
type I interferon production
|
The appearance of type I interferon due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Type I interferons include the interferon-alpha, beta, delta, episilon, zeta, kappa, tau, and omega gene families.
|
TBK1
|
GO:0032607
|
BP
|
interferon-alpha production
|
The appearance of interferon-alpha due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
AZI2
|
GO:0032609
|
BP
|
interferon-gamma production
|
The appearance of interferon-gamma due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels. Interferon-gamma is also known as type II interferon.
|
TLR4,
AVPR2,
LILRB1,
AZI2
|
GO:0032611
|
BP
|
interleukin-1 beta production
|
The appearance of interleukin-1 beta due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
IL1B,
CASP1,
MR1,
PYCARD
|
GO:0032613
|
BP
|
interleukin-10 production
|
The appearance of interleukin-10 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
TLR2,
CD46,
PRKCD
|
GO:0032615
|
BP
|
interleukin-12 production
|
The appearance of interleukin-12 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
LEP,
PRKCD
|
GO:0032618
|
BP
|
interleukin-15 production
|
The appearance of interleukin-15 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
TUSC2
|
GO:0032620
|
BP
|
interleukin-17 production
|
The appearance of any member of the interleukin-17 family of cytokines due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
RFTN1,
MR1
|
GO:0032623
|
BP
|
interleukin-2 production
|
The appearance of interleukin-2 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
SLC11A1
|
GO:0032632
|
BP
|
interleukin-3 production
|
The appearance of interleukin-3 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
SLC11A1
|
GO:0032635
|
BP
|
interleukin-6 production
|
The appearance of interleukin-6 due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
AZI2,
ASH1L
|
GO:0032640
|
BP
|
tumor necrosis factor production
|
The appearance of tumor necrosis factor due to biosynthesis or secretion following a cellular stimulus, resulting in an increase in its intracellular or extracellular levels.
|
AZI2
|
GO:0032642
|
BP
|
regulation of chemokine production
|
Any process that modulates the frequency, rate, or extent of chemokine production.
|
SNAI2
|
GO:0032648
|
BP
|
regulation of interferon-beta production
|
Any process that modulates the frequency, rate, or extent of interferon-beta production.
|
TRIM38,
TIRAP,
RNF216
|
GO:0032649
|
BP
|
regulation of interferon-gamma production
|
Any process that modulates the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
ISG15
|
GO:0032651
|
BP
|
regulation of interleukin-1 beta production
|
Any process that modulates the frequency, rate, or extent of interleukin-1 beta production.
|
F2R,
S1PR3,
SPHK1
|
GO:0032652
|
BP
|
regulation of interleukin-1 production
|
Any process that modulates the frequency, rate, or extent of interleukin-1 production.
|
ANXA1
|
GO:0032667
|
BP
|
regulation of interleukin-23 production
|
Any process that modulates the frequency, rate, or extent of interleukin-23 production.
|
TGFB1
|
GO:0032674
|
BP
|
regulation of interleukin-5 production
|
Any process that modulates the frequency, rate, or extent of interleukin-5 production.
|
IL5RA
|
GO:0032675
|
BP
|
regulation of interleukin-6 production
|
Any process that modulates the frequency, rate, or extent of interleukin-6 production.
|
MAPKAPK2,
AFAP1L2
|
GO:0032680
|
BP
|
regulation of tumor necrosis factor production
|
Any process that modulates the frequency, rate, or extent of tumor necrosis factor production.
|
ZFP36,
MAPKAPK2,
ANGPT1,
FOXP1,
TBC1D23
|
GO:0032688
|
BP
|
negative regulation of interferon-beta production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-beta production.
|
PPM1B,
RELB,
REL,
PYCARD
|
GO:0032689
|
BP
|
negative regulation of interferon-gamma production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
TLR4,
IL33,
PRNP,
HMGB1,
IL10,
TNFSF4,
IL1RL1,
C1QBP,
GAS6,
LILRB1,
PGLYRP2,
FOXP3
|
GO:0032691
|
BP
|
negative regulation of interleukin-1 beta production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 beta production.
|
GSTP1,
TNFAIP3,
CHRNA7,
GHSR,
GHRL,
ERRFI1
|
GO:0032692
|
BP
|
negative regulation of interleukin-1 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-1 production.
|
IL10,
NR1H4
|
GO:0032693
|
BP
|
negative regulation of interleukin-10 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-10 production.
|
PRG2,
JAK3,
FOXP3
|
GO:0032695
|
BP
|
negative regulation of interleukin-12 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-12 production.
|
THBS1,
IL10,
JAK3,
C1QBP,
PIBF1,
IRAK3
|
GO:0032700
|
BP
|
negative regulation of interleukin-17 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
TLR4,
TUSC2,
TGFB1,
PRNP,
TNFSF4,
IL12A,
FOXP3
|
GO:0032701
|
BP
|
negative regulation of interleukin-18 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-18 production.
|
IL10
|
GO:0032703
|
BP
|
negative regulation of interleukin-2 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-2 production.
|
PRNP,
TNFAIP3,
HDAC7,
NR1H4,
FOXP3,
VSIG4
|
GO:0032707
|
BP
|
negative regulation of interleukin-23 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-23 production.
|
TLR4,
RAC1
|
GO:0032713
|
BP
|
negative regulation of interleukin-4 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-4 production.
|
CD83,
NDFIP1,
FOXP3
|
GO:0032714
|
BP
|
negative regulation of interleukin-5 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-5 production.
|
FOXP3
|
GO:0032715
|
BP
|
negative regulation of interleukin-6 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-6 production.
|
TLR4,
SOCS5,
TNF,
ORM1,
HGF,
TNFAIP3,
IL10,
CHRNA7,
CSK,
GAS6,
NR1H4,
VIMP,
FOXP3,
KLF2,
IRAK3
|
GO:0032717
|
BP
|
negative regulation of interleukin-8 production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of interleukin-8 production.
|
IL10,
OTUD7B
|
GO:0032720
|
BP
|
negative regulation of tumor necrosis factor production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of tumor necrosis factor production.
|
TLR4,
POMC,
ORM1,
GSTP1,
TNFAIP3,
IL10,
TSPO,
CHRNA7,
HSF1,
GAS6,
GPNMB,
TWIST1,
ADIPOQ,
VIMP,
FOXP3,
NFKBIL1,
PTPN22,
IRAK3
|
GO:0032722
|
BP
|
positive regulation of chemokine production
|
Any process that activates or increases the frequency, rate, or extent of chemokine production.
|
TLR4,
TLR3,
RIPK2,
TLR2,
TNF,
IL6,
IL6R,
ADORA2B,
ADAM17,
HIF1A
|
GO:0032725
|
BP
|
positive regulation of granulocyte macrophage colony-stimulating factor production
|
Any process that activates or increases the frequency, rate, or extent of granulocyte macrophage colony-stimulating factor production.
|
IL1B,
PAEP,
IL18
|
GO:0032727
|
BP
|
positive regulation of interferon-alpha production
|
Any process that activates or increases the frequency, rate, or extent of interferon-alpha production.
|
TLR4,
RIPK2,
HSPD1,
MAVS,
TBK1
|
GO:0032728
|
BP
|
positive regulation of interferon-beta production
|
Any process that activates or increases the frequency, rate, or extent of interferon-beta production.
|
TLR4,
DDX3X,
POLR3G,
TLR3,
RIPK2,
TLR2,
FLOT1,
IRF1,
IFNAR1,
HMGB2,
MAVS,
POLR3C,
POLR3F,
ZBTB20,
POLR3B,
TBK1
|
GO:0032729
|
BP
|
positive regulation of interferon-gamma production
|
Any process that activates or increases the frequency, rate, or extent of interferon-gamma production. Interferon-gamma is also known as type II interferon.
|
TLR4,
RIPK2,
SASH3,
TNF,
IL1B,
CD14,
HSPD1,
IFNAR1,
HLA-DPA1,
BCL3,
ZP3,
TNFSF4,
IL12A,
WNT5A,
IL12RB1,
SLC11A1,
PDE4D,
FADD,
IL18R1,
IL18,
PYCARD
|
GO:0032731
|
BP
|
positive regulation of interleukin-1 beta production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-1 beta production.
|
JAK2,
HSPB1,
SMAD3,
IFI16
|
GO:0032732
|
BP
|
positive regulation of interleukin-1 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-1 production.
|
TLR4,
HDAC1,
HDAC2
|
GO:0032733
|
BP
|
positive regulation of interleukin-10 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-10 production.
|
TLR4,
TLR2,
TUSC2,
SASH3,
HMGB1,
CD28,
HSPD1,
HGF,
CD46,
TNFSF4,
CD40LG,
CD83,
PIBF1
|
GO:0032735
|
BP
|
positive regulation of interleukin-12 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-12 production.
|
TLR4,
TLR3,
RIPK2,
TLR2,
HMGB1,
HSPD1,
CD36,
HLA-G,
TNFSF4,
CD40LG,
TIRAP,
PLCB1
|
GO:0032736
|
BP
|
positive regulation of interleukin-13 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-13 production.
|
IL33,
HLA-E,
TNFSF4,
IL1RAP
|
GO:0032738
|
BP
|
positive regulation of interleukin-15 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-15 production.
|
TIRAP
|
GO:0032740
|
BP
|
positive regulation of interleukin-17 production
|
Any process that activates or increases the frequency, rate, or extent of production of any member of the interleukin-17 family of cytokines.
|
TGFB1,
PRKCQ,
IL18
|
GO:0032741
|
BP
|
positive regulation of interleukin-18 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-18 production.
|
TLR2
|
GO:0032743
|
BP
|
positive regulation of interleukin-2 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-2 production.
|
MAP3K7,
RIPK2,
SASH3,
ANXA1,
TNFSF4,
CD83,
RUNX1,
PDE4D,
PRKD2
|
GO:0032753
|
BP
|
positive regulation of interleukin-4 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-4 production.
|
SASH3,
IL33,
CD28,
PRG2,
HLA-E,
CEBPB,
ZP3,
TNFSF4,
CD40LG,
PRKCQ,
FOXP3
|
GO:0032754
|
BP
|
positive regulation of interleukin-5 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-5 production.
|
IL33,
IL1RL1,
PDE4D,
IL1RAP
|
GO:0032755
|
BP
|
positive regulation of interleukin-6 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-6 production.
|
TLR4,
MAPK13,
TLR3,
RIPK2,
TLR2,
IL33,
TNF,
IL1A,
IL1B,
IL6,
IL6R,
HSPD1,
CD36,
TNFSF4,
ADORA2B,
WNT5A,
ARHGEF2,
SPON2,
ZBTB20,
TBC1D23,
PYCARD
|
GO:0032757
|
BP
|
positive regulation of interleukin-8 production
|
Any process that activates or increases the frequency, rate, or extent of interleukin-8 production.
|
TLR4,
TLR3,
TLR5,
TLR2,
TNF,
IL1B,
SERPINE1,
HSPA1A,
HSPA1B,
DDIT3,
TIRAP,
FADD,
RIPK1,
ADIPOQ,
MAVS,
AFAP1L2,
PRKD2,
ZNF580
|
GO:0032759
|
BP
|
positive regulation of TRAIL production
|
Any process that activates or increases the frequency, rate, or extent of TRAIL production.
|
HLA-E
|
GO:0032760
|
BP
|
positive regulation of tumor necrosis factor production
|
Any process that activates or increases the frequency, rate, or extent of tumor necrosis factor production.
|
TLR4,
TLR3,
RIPK2,
TLR2,
JAK2,
SASH3,
PF4,
CD14,
CCL3,
CLU,
CCL2,
HLA-E,
CD36,
PTAFR,
PIK3R1,
LEP,
TIRAP,
FADD,
RIPK1,
HDAC1,
NFATC4,
TWIST1,
MAVS,
HDAC2,
ARHGEF2,
SPON2,
ZBTB20,
PYCARD,
ARFGEF2
|
GO:0032762
|
BP
|
mast cell cytokine production
|
Any process that contributes to cytokine production by a mast cell.
|
KIT
|
GO:0032764
|
BP
|
negative regulation of mast cell cytokine production
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of mast cell cytokine production.
|
HMOX1,
BCL6
|
GO:0032765
|
BP
|
positive regulation of mast cell cytokine production
|
Any process that activates or increases the frequency, rate, or extent of mast cell cytokine production.
|
BCL10,
NR4A3
|
GO:0032769
|
BP
|
negative regulation of monooxygenase activity
|
Any process that stops or reduces the activity of a monooxygenase.
|
SNCA
|
GO:0032775
|
BP
|
DNA methylation on adenine
|
The covalent transfer of a methyl group to N-6 of adenine in a DNA molecule.
|
METTL4
|
GO:0032780
|
BP
|
negative regulation of ATPase activity
|
Any process that stops or reduces the rate of ATP hydrolysis by an ATPase.
|
TNNI3,
PLN,
PPIF,
CNN3,
PXK,
PAM16
|
GO:0032781
|
BP
|
positive regulation of ATPase activity
|
Any process that activates or increases the rate of ATP hydrolysis by an ATPase.
|
DNAJB6,
ATP1B1,
PFN1,
TPM1,
MYL4,
DNAJB1,
ATP1B3,
GABARAPL2,
RGN,
AHSA2,
DNAJC10,
DNAJC9,
DNAJC1,
DNAJC7
|
GO:0032784
|
BP
|
regulation of DNA-templated transcription, elongation
|
Any process that modulates the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.
|
TCEA3,
TSFM,
ZNF326,
CCAR2
|
GO:0032785
|
BP
|
negative regulation of DNA-templated transcription, elongation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.
|
SUPT5H
|
GO:0032786
|
BP
|
positive regulation of DNA-templated transcription, elongation
|
Any process that activates or increases the frequency, rate or extent of transcription elongation, the extension of an RNA molecule after transcription initiation and promoter clearance by the addition of ribonucleotides catalyzed by a DNA-dependent RNA polymerase.
|
SUPT5H,
ALYREF,
SUPT16H
|
GO:0032787
|
BP
|
monocarboxylic acid metabolic process
|
The chemical reactions and pathways involving monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-).
|
CYP2C9
|
GO:0032788
|
BP
|
saturated monocarboxylic acid metabolic process
|
The chemical reactions and pathways involving saturated monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-) and fully saturated C-C bonds.
|
ACOT4
|
GO:0032789
|
BP
|
unsaturated monocarboxylic acid metabolic process
|
The chemical reactions and pathways involving unsaturated monocarboxylic acids, any organic acid containing one carboxyl (COOH) group or anion (COO-) and one or more unsaturated C-C bonds.
|
ACOT4
|
GO:0032790
|
BP
|
ribosome disassembly
|
The disaggregation of a ribosome into its constituent components; includes the dissociation of ribosomal subunits.
|
DENR,
MTIF3,
HBS1L
|
GO:0032792
|
BP
|
negative regulation of CREB transcription factor activity
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of the transcription factor CREB.
|
DDIT3,
SIK1,
FOXP3,
EIF2AK4
|
GO:0032793
|
BP
|
positive regulation of CREB transcription factor activity
|
Any process that activates or increases the frequency, rate or extent of activity of the transcription factor CREB.
|
RPS6KA5,
VEGFA,
EPHA5,
PRKD1,
CRTC3,
CAMK1D,
PRKD2
|
GO:0032796
|
BP
|
uropod organization
|
A process that is carried out at the cellular level which results in the assembly, arrangement of constituent parts, or disassembly of a uropod, a rigid membrane projection with related cytoskeletal components at the trailing edge of a lymphocyte or other cell in the process of migrating or being activated.
|
CORO1A,
MYH9
|
GO:0032800
|
BP
|
receptor biosynthetic process
|
The chemical reactions and pathways resulting in the formation of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
TNF,
IL10
|
GO:0032801
|
BP
|
receptor catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
TGFB1,
CDK5,
PIK3R4,
SH3GLB1
|
GO:0032802
|
BP
|
low-density lipoprotein particle receptor catabolic process
|
The chemical reactions and pathways resulting in the breakdown of a low-density lipoprotein particle receptor molecule, a macromolecule that undergoes combination with a hormone, neurotransmitter, drug or intracellular messenger to initiate a change in cell function.
|
PCSK9
|
GO:0032803
|
BP
|
regulation of low-density lipoprotein particle receptor catabolic process
|
Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein particle receptors.
|
MYLIP
|
GO:0032804
|
BP
|
negative regulation of low-density lipoprotein particle receptor catabolic process
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein receptors.
|
ANXA2,
FURIN
|
GO:0032805
|
BP
|
positive regulation of low-density lipoprotein particle receptor catabolic process
|
Any process that activates or increases the frequency, rate or extent of the chemical reactions and pathways resulting in the breakdown of low-density lipoprotein particle receptors.
|
APOE,
PCSK9
|
GO:0032808
|
BP
|
lacrimal gland development
|
The process whose specific outcome is the progression of the lacrimal gland over time, from its formation to the mature structure. The lacrimal gland produces secretions that lubricate and protect the cornea of the eye.
|
FGFR2,
SOX9,
FOXC1
|
GO:0032811
|
BP
|
negative regulation of epinephrine secretion
|
Any process that stops, prevents, or reduces the frequency, rate or extent of the regulated release of epinephrine.
|
ADRA2B
|
GO:0032812
|
BP
|
positive regulation of epinephrine secretion
|
Any process that activates or increases the frequency, rate or extent of the regulated release of epinephrine.
|
CARTPT
|
GO:0032814
|
BP
|
regulation of natural killer cell activation
|
Any process that modulates the frequency, rate or extent of natural killer cell activation.
|
LEP
|
GO:0032815
|
BP
|
negative regulation of natural killer cell activation
|
Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell activation.
|
MICA,
PIBF1
|
GO:0032816
|
BP
|
positive regulation of natural killer cell activation
|
Any process that activates or increases the frequency, rate or extent of natural killer cell activation.
|
IL12A,
BLOC1S6
|
GO:0032817
|
BP
|
regulation of natural killer cell proliferation
|
Any process that modulates the frequency, rate or extent of natural killer cell proliferation.
|
LEP,
PTPN22
|
GO:0032819
|
BP
|
positive regulation of natural killer cell proliferation
|
Any process that activates or increases the frequency, rate or extent of natural killer cell proliferation.
|
STAT5B,
IL18,
CD244
|
GO:0032825
|
BP
|
positive regulation of natural killer cell differentiation
|
Any process that activates or increases the frequency, rate or extent of natural killer cell differentiation.
|
STAT5B,
GAS6
|
GO:0032827
|
BP
|
negative regulation of natural killer cell differentiation involved in immune response
|
Any process that stops, prevents, or reduces the frequency, rate or extent of natural killer cell differentiation as part of an immune response.
|
PGLYRP2
|
GO:0032831
|
BP
|
positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation
|
Any process that activates or increases the frequency, rate or extent of differentiation of CD4-positive, CD25-positive, alpha-beta regulatory T cells.
|
FOXP3
|
GO:0032835
|
BP
|
glomerulus development
|
The progression of the glomerulus over time from its initial formation until its mature state. The glomerulus is a capillary tuft which forms a close network with the visceral epithelium (podocytes) and the mesangium to form the filtration barrier and is surrounded by Bowman's capsule in nephrons of the vertebrate kidney. The glomerulus is part of the nephron and is restricted to one body segment.
|
TCF21,
BCL2,
WT1,
PTPRO,
HEYL
|
GO:0032836
|
BP
|
glomerular basement membrane development
|
The process whose specific outcome is the progression of the glomerular basement membrane over time, from its formation to the mature structure. The glomerular basement membrane is the basal laminal portion of the glomerulus which performs the actual filtration.
|
NID1,
WT1,
MPV17,
COL4A3,
MYO1E,
SULF2,
SULF1
|
GO:0032848
|
BP
|
negative regulation of cellular pH reduction
|
Any process that stops, prevents, or reduces the frequency, rate, or extent of a process that reduces the internal pH of a cell.
|
BCL2
|
GO:0032849
|
BP
|
positive regulation of cellular pH reduction
|
Any process that activates or increases the frequency, rate, or extent of a process that reduces the internal pH of a cell.
|
CA2
|
GO:0032868
|
BP
|
response to insulin
|
Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
AGRP,
OGT,
TLR2,
IL6,
FABP3,
LYN,
EGR2,
PFKFB1,
EGR1,
IL10,
GAL,
PLN,
CAD,
MC4R,
ADM,
PCK1,
IRS1,
LEP,
TNFSF10,
UCP3,
EIF6,
SESN2,
SESN3,
HSD11B2,
RELA,
PPARA,
SRSF6,
CRY1,
HADH,
SLC27A1,
EPM2AIP1,
GGH,
UPRT,
CITED1,
TRPV4,
RETN
|
GO:0032869
|
BP
|
cellular response to insulin stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an insulin stimulus. Insulin is a polypeptide hormone produced by the islets of Langerhans of the pancreas in mammals, and by the homologous organs of other organisms.
|
TBC1D4,
INSR,
APRT,
GSTP1,
INHBB,
PARP1,
CCL2,
SLC2A4,
RHOQ,
XBP1,
SRD5A1,
ENPP1,
PIK3R1,
AKT1,
AKT2,
PCK1,
IRS1,
PPARG,
PRKCI,
GCLC,
STAR,
UCP2,
VAMP2,
PRKDC,
GPLD1,
PPAT,
ZFP36L1,
FOXO1,
SRSF5,
PDE3B,
RAB31,
LPIN1,
ADIPOQ,
DENND4C,
CPEB2,
C2CD5,
PCSK9,
KAT2B,
GHSR,
TRIB3,
VIMP,
INPP5K,
SORBS1,
CAPN10,
ERRFI1,
HDAC9,
HDAC5,
IRS2,
MYO5A
|
GO:0032870
|
BP
|
cellular response to hormone stimulus
|
Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a hormone stimulus.
|
SOCS2,
SLIT2,
FOS,
JUN,
ASNS,
GHR,
CYP11B1,
JUNB,
JUND,
IGFBP2,
CYP11B2,
DUSP1,
AVPR2,
OXTR,
STAT3,
PGF,
STAT5B,
FOSB,
UCP3,
SIK1,
NCOA2,
NCOA1,
IGFBP7,
INPP5K,
SIK2,
ROBO2
|
GO:0032872
|
BP
|
regulation of stress-activated MAPK cascade
|
Any process that modulates the frequency, rate or extent of signal transduction mediated by the stress-activated MAPK cascade.
|
GSTP1,
MAPK3,
MAPK1,
MAP2K2,
MAP2K1,
PRDX1,
NBR1
|